Table 2.
Genotype and gene | Mutation/deletion (nts or aa) | Motif | Infectious clone | Growthd | GenBank | |
---|---|---|---|---|---|---|
II | 5′UTR | 1–3 nts | N/A | pAPRRS | N/A | GQ330474.2 |
II | nsp2 | 13–35 aa | hypervariable | pVR-V7 | ↓ | DQ217415 |
II | nsp2 | 324–726 aa | hypervariable | pVR-V7 | ↓ | DQ217415 |
II | nsp2 | 727–813 aa | hypervariable | pVR-V7 | ↓ | DQ217415 |
II | nsp2 | 480–667 aa | hypervariable | pHuN4-F112 | N/A | EF635006 |
I | nsp2 | 691–722 aa | ES3a | pSD01-08 | ↑ | DQ489311 |
I | nsp2 | 736–790 aa | ES4a | pSD01-08 | nc | DQ489311 |
I | nsp2 | 1015–1040 aa | ES7a | pSD01-08 | ↓ | DQ489311 |
II | ORF7 | 5–13 aa | N/A | pAPRRS | ↓ | GQ330474.2 |
II | ORF7 | 39–42 aa | N/A | pAPRRS | ↓ | GQ330474.2 |
II | ORF7 | 48–52 aa | N/A | pAPRRS | nc | GQ330474.2 |
II | ORF7 | 120–123 aa | N/A | pAPRRS | nc | GQ330474.2 |
II | ORF7 | 43,44 aa | NLSb | pCMV-S-P129 | ↓ | AF494042 |
II | ORF7 | 43,44,46 aa | NLSb | pCMV-S-P129 | ↓ | AF494042 |
II | ORF7 | 46,47 aa | NLSb | pCMV-S-P129 | ↓ | AF494042 |
I | ORF7 | 123–128 aa | N/A | pABV437 | nc | N/A |
I | 3′UTR | 14989–14995 nts | N/A | pABV437 | nc | N/A |
II | 3′UTR | 15370–15409 nts | N/A | pAPRRS | N/A | GQ330474.2 |
N/A, not application. “nc” stands for no change.
The abbreviation, ES, stands for the immunodominant B-cell epitopes identified in type I PRRSV.ES2-ES7 are identified in nsp2 encoding regions (Oleksiewicz et al., 2001).
NLS stands for the nuclear localization signal which mediates the nuclear localization of PRRSV N protein.
c Ref. Seq. is the abbreviation of reference sequence, and GenBank accession numbers for each construct are provided.
Symbols “↑” and “↓” indicate increased or reduced virus growth respectively.